“It’s not harder to get drug approvals right now, it’s harder to get vaccine approvals,” Bourla said Wednesday during a wide-ranging conversation with CNBC that waded into his company’s US investments, deal with the Trump administration and the country’s current regulatory environment.
As the nation’s top health official, Kennedy has made sweeping changes to long-standing vaccine policies while casting doubts on the safety and effectiveness of widely used ...